Home
Novartis Venture Fund

Novartis Venture Fund Market Share Analysis for May 2026

The Novartis Venture Fund has a portfolio model built around making focused equity investments in biotechnology and biopharma life sciences companies, whatever their stage of development

Finance > Investing

Domainnvfund.com

Year Founded1996

Employees51 - 200

Annual Revenue$25M - $50M

Novartis Venture Fund

Novartis Venture Fund (including company regionals)

nvfund.com

See more website traffic and engagement information

Novartis Venture Fund Revenue up to May 2026 is 25M - 50M

revenue generated by Novartis Venture Fund top domains

Novartis Venture Fund top domains revenue over 3 years

Revenue for Novartis Venture Fund top domains

nvfund.com25M - 50M

See more with Sales Intelligence

Total visits to Novartis Venture Fund's top domains

Understand Novartis Venture Fund market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

nvfund.com5.4K

See more with Sales Intelligence

Avg. visit duration in Novartis Venture Fund's top domains

Analyze Novartis Venture Fund engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

nvfund.com00:00:38

See more with Sales Intelligence

Avg. pageviews on Novartis Venture Fund's top domains

See how Novartis Venture Fund keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

nvfund.com2.06

See more with Sales Intelligence

Novartis Venture Fund top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Novartis Venture Fund

These are the website technologies, by industry, used by Novartis Venture Fund top domains

Conversion & Analytics (2)

Google Analytics

Marketing (2)

Google Marketing Platform

Advertising (1)

adresult

Business Solutions (1)

DocuSign

More Technologies

5

See all

News & Signals from Novartis Venture Fund

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNovartis Venture Fund invests into Averna Therapeutics Inc. $82M in Series A.Averna launched in 2024 with an $82 million Series A financing co-led by Novartis Venture Fund and Delos Capital, with participation from OrbiMed, Insight Partners, J.P. Morgan Life Sciences Private Capital, CRISPR Therapeutics, Innovation Endeavors, Invus, Arc Ventures and Deep Insight.

NewsNovartis Venture Fund invested into LoQus23 Therapeutics Ltd. $44.8M in Series A on Oct 1st '24.In October 2024, LoQus23 announced the successful close of its £35 million Series A financing round led by Forbion, alongside existing investors SV Health Investors' Dementia Discovery Fund and Novartis Venture Fund.

NewsNovartis Venture Fund invests into Citryll $93.9M in Series B.Pivot Park is proud to celebrate Citryll's €85 million Series B financing, led by Johnson & Johnson Innovation JJDC Inc, Forbion, and Novartis Venture Fund, alongside other existing stakeholders.